# Investigating the effects of percutaneous endovascular aneurysm repair for abdominal aortic aneurysm on the lumen size of the common femoral artery

**Authors:** Wilson Wei Xiang Ong, Hsien Ts’ung Tay, Tze Tec Chong

PMC · DOI: 10.1186/s42155-024-00476-0 · CVIR Endovascular · 2024-09-10

## TL;DR

This study examines how a common treatment for abdominal aortic aneurysms affects the size of a key artery in the groin, focusing on Asian patients.

## Contribution

The study provides new insights into anatomical changes in the common femoral artery after PEVAR in an Asian cohort, addressing ethnic differences.

## Key findings

- PEVAR leads to a statistically significant decrease in common femoral artery inner and outer diameters.
- The observed changes were below flow-limiting thresholds, indicating minimal risk of complications.
- Results remained consistent even after accounting for cardiovascular risk factors like diabetes and hypertension.

## Abstract

Percutaneous endovascular aneurysm repair (PEVAR) is the definitive therapy of choice for abdominal aortic aneurysms worldwide. However, current literature regarding the anatomic changes in the common femoral artery (CFA) post-PEVAR is sparse and contradictory, and a significant proportion of these studies did not control for the potential confounding effects of ethnicity. Thus, this study aims to investigate the anatomical effects of PEVAR on the CFA using an Asian study cohort.

Between January 2019 and September 2023, the records of 113 patients who received PEVAR were reviewed. Groins with previous surgical interventions were excluded. The most proximate pre- and postoperative CT angiography of patients receiving PEVAR via the Perclose ProGlide™ Suture-Mediated Closure System were retrospectively analysed for changes in both the CFA inner luminal diameter (ID) and outer diameter (OD), the latter also encompassing the arterial walls. Access site complications within 3 months post-PEVAR were also recorded per patient.

One hundred seventeen groins from 60 patients were included in this study, with 1 report of pseudoaneurysm. The CFA ID exhibited a 0.167 mm decrease (p-value = 0.0403), while the OD decreased by 0.247 mm (p-value = 0.0107). This trend persisted when the data was separately analysed with the common cardiovascular risk factors of diabetes mellitus, hypertension and hyperlipidaemia.

Our analysis demonstrated a statistically significant decrease in the CFA diameters post-PEVAR. However, the percentage changes were below established flow-limiting values, as reflected by the single access site complication reported. Hence, our findings give confidence in the safety profile of this procedure, even with the reported smaller baseline CFA lumen size in Asians. Moving forward, similar longer-term studies should be considered to characterise any late postoperative effects.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015), hyperlipidaemia (MONDO:0001336)

## Full-text entities

- **Diseases:** aneurysm (MESH:D000783), hypertension (MESH:D006973), abdominal aortic aneurysm (MESH:D017544), pseudoaneurysm (MESH:D017541), diabetes mellitus (MESH:D003920)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11387579/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11387579/full.md

---
Source: https://tomesphere.com/paper/PMC11387579